Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

DEXCOM, INC.

(DXCM)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/27/2020 11/30/2020 12/01/2020 12/02/2020 12/03/2020 Date
318.21(c) 319.68(c) 327.72(c) 333.2(c) 344.63(c) Last
586 123 2 212 324 1 557 238 1 116 893 1 729 665 Volume
+1.81% +0.46% +2.52% +1.67% +3.43% Change
More quotes
Financials (USD)
Sales 2020 1 910 M - -
Net income 2020 235 M - -
Net Debt 2020 306 M - -
P/E ratio 2020 144x
Yield 2020 -
Sales 2021 2 333 M - -
Net income 2021 328 M - -
Net Debt 2021 9,13 M - -
P/E ratio 2021 105x
Yield 2021 -
Capitalization 33 094 M 33 094 M -
EV / Sales 2020 17,5x
EV / Sales 2021 14,2x
Nbr of Employees 3 900
Free-Float 98,8%
More Financials
Company
DexCom, Inc. specialises in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 78.7% of net sales. 
Sector
Medical Equipment, Supplies & Distribution
Calendar
12/09 | 11:30amInvestor Day
More about the company
Notations Surperformance© of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about DEXCOM, INC.
11/12DEXCOM : Announces Upcoming Virtual Conference Presentations
BU
11/03DEXCOM : to Host Investor Day on December 9, 2020
BU
10/27DEXCOM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
10/27DEXCOM : 3Q Earnings Snapshot
AQ
10/27DEXCOM INC : Results of Operations and Financial Condition, Financial Statements..
AQ
10/27DEXCOM : Reports Third Quarter 2020 Financial Results
BU
10/26DEXCOM INC : Results of Operations and Financial Condition, Change in Directors ..
AQ
10/26DEXCOM : Announces Retirement of Rick Doubleday and Pre-Announcement of Third Qu..
BU
10/23Covid-19 Continues to Boost and Bust S&P 500 Companies
DJ
10/22DEXCOM, INC. : quaterly earnings release
10/13DEXCOM INC : Change in Directors or Principal Officers, Other Events, Financial ..
AQ
10/13DEXCOM : Appoints Kyle Malady to Board of Directors
BU
10/08ELI LILLY AND COMPANY : - Lilly and Dexcom team up on new program to help improv..
AQ
10/07DEXCOM : Lilly and Dexcom team up on new program to help improve diabetes manage..
PR
10/01DEXCOM SCHEDULES THIRD QUARTER 2020 : 30 p.m. Eastern Time.
BU
More news
News in other languages on DEXCOM, INC.
11/20DEXCOM : Le système Dexcom G6 de mesure en continu du glucose bientôt remboursé ..
10/22DEXCOM, INC. : publication des résultats trimestriels
10/22DEXCOM, INC. : Veröffentlichung des Quartalsergebnisses
07/23DEXCOM, INC. : publication des résultats semestriels
07/23DEXCOM, INC. : Veröffentlichung des Halbjahresergebnisses
More news
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | MarketScreener
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 444,44 $
Last Close Price 344,63 $
Spread / Highest target 46,2%
Spread / Average Target 29,0%
Spread / Lowest Target -39,9%
EPS Revisions
Managers
NameTitle
Kevin Ronald Sayer Chairman, President & Chief Executive Officer
Quentin S. Blackford Chief Operating & Financial Officer
Andrew K. Balo EVP-Clinical Affairs, Regulatory Strategies
Jacob Leach Chief Technology Officer & Executive VP
Shelly R. Selvaraj Senior Vice President-Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.57.55%33 094
ABBOTT LABORATORIES23.80%191 681
MEDTRONIC PLC-0.86%152 346
BECTON, DICKINSON AND COMPANY-12.30%70 150
HOYA CORPORATION24.59%48 552
ALIGN TECHNOLOGY, INC.83.39%39 857